DNAnexus Introduces Innovative Clinico-Genomic Browser to Allow Diverse Research Teams to Explore Complex Human Data Sets

The Regeneron Genetics Center successfully deployed the cohort browser against a large genomic and phenotypic UK Biobank data set March 11, 2019 09:15 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™... Read more

Nuvec®: A breakthrough technology for mRNA / pDNA delivery for vaccines and cancer treatments

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, is developing Nuvec® – a unique non-viral adjuvant delivery system for vaccines and cancer treatments. This silica nanoparticle has the potential to help commercialize cancer immunotherapy drugs and improve the effectiveness of viral vaccines. Nuvec® silica nanoparticles have a unique irregular (spikey) surface structure, coupled with... Read more

Novel enzyme from LGC, Biosearch Technologies is fast and specific, even at room temperature

LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase (RT) designed specifically to meet the needs of diagnostic kit developers.   This reverse transcriptase has a temperature optimum from 55 – 80 °C, improving reaction specificity and allowing synthesis from diverse RNA templates.  It is also fast, with a reaction time of five... Read more

IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system

Mar 6, 2019 CORALVILLE, IA (March 6, 2019) – As a dedicated innovator of tools and solutions for genomics applications, Integrated DNA Technologies (IDT) introduces its unique, rhAmpSeq™ targeted sequencing system – providing researchers with highly accurate, cost-effective and easy-to-use amplicon sequencing on Illumina® next-generation sequencing (NGS) platforms. The proprietary rhAmpSeq chemistry enables multiplexing at impressive levels with high on-target rates... Read more

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

M ST. LOUIS, March 5, 2019 /PRNewswire/ — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation sequencing (NGS) from Washington University.  This license includes both a novel method and bioinformatic tools that combine to significantly improve... Read more

MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

04 MAR 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects Marks MilliporeSigma’s 13th CRISPR patent overall Actively licensing CRISPR-related patents to interested parties Burlington, Massachusetts, March 4, 2019 – MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed... Read more

Lexogen Launches CORALL – The New Stranded Whole Transcriptome Library Prep Kit for Illumina®

Vienna, Austria, February 28, 2019 / PRNewswire/ – Today Lexogen announced the launch of the CORALL Total RNA-Seq Library Prep Kit. This new all-in-one library prep kit can be used for all whole transcriptome analysis applications such as differential expression, isoform quantification, single nucleotide polymorphism (SNP), and mutation detection. “RNA-Seq library preparation protocols are still plagued by... Read more

Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle Inc.

Indianapolis, Indiana (February 28, 2019) – At the Advances in Genome Biology and Technology (AGBT) General Meeting*, Beckman Coulter Life Sciences announces the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company. As cfDNA workflows move beyond theoretical and into human health applications, Apostle’s industry leading chemistry... Read more

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. Barclays Global Healthcare Conference in Miami Beach, FLWednesday, March 13, 2019 at 11:15 am Eastern Time The live webcast can be accessed in the Investor Relations section of Illumina’s web... Read more

Agilent Announces New Library Preparation System for Next Generation Sequencing

Agilent Announces New Library Preparation System for Next Generation Sequencing Fully automated Magnis system delivers reproducible results for molecular laboratories SANTA CLARA, Calif., February 28, 2019 Agilent Technologies, Inc. (NYSE: A) today announced a new next-generation sequencing (NGS) library preparation system designed to easily run complex DNA sequencing assays with the press of a button.... Read more